Drugs / intestinal microbiota capsules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06931808 | Mar 2025 → Mar 2026 overdue | rectum adenocarcinoma | First Affiliated Hospital of Ningbo University | Enrolling by invitation | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intestinal microbiota capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06931808 ↗ |
| Modality | Other / unclassified | “intestinal microbiota transplantation treatment” NCT06931808 ↗ |
| Route | Oral | “oral intestinal microbiota capsules are used for transplantation treatment” NCT06931808 ↗ |